A dietary treatment improves cerebral blood flow and brain connectivity in aging apoE4 mice

Neural Plasticity

Volumn 2016, Issue , 2016, Pages

  Wiesmann, Maximilian ^a,b   Zerbi, Valerio ^a,b   Jansen, Diane ^a   Haast, Roy ^a   Lütjohann, Dieter ^c   Broersen, Laus M ^d,e   Heerschap, Arend ^b   Kiliaan, Amanda J ^a  

^a RADBOUD UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BONN   (Germany)

^d DANONE NUTRICIA RESEARCH   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN E4; ASCORBIC ACID; CHOLINE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FATTY ACID; FOLIC ACID; ICOSAPENTAENOIC ACID; PHOSPHOLIPID; POSTSYNAPTIC DENSITY PROTEIN 95; PYRIDOXINE; SELENIUM; STEROL; URIDINE; APOLIPOPROTEIN E; DLGH4 PROTEIN, MOUSE; GUANYLATE KINASE; MEMBRANE PROTEIN;

AGED; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; DIET THERAPY; FATTY ACID BLOOD LEVEL; FEMALE; GENOTYPE; GRAY MATTER; MALE; MOUSE; NERVE CELL NETWORK; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTSYNAPTIC DENSITY; WHITE MATTER; ANIMAL; BLOOD; BRAIN; BRAIN MAPPING; C57BL MOUSE; DIET; GENETICS; METABOLISM; NERVE TRACT; PATHOPHYSIOLOGY; TRANSGENIC MOUSE; VASCULARIZATION;

AGING; ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; BRAIN MAPPING; DIET; FATTY ACIDS; FEMALE; GUANYLATE KINASES; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURAL PATHWAYS; STEROLS;

EID: 84962070978     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2016/6846721     Document Type: Article

References (85)

1. F. Sofi, F. Cesari, R. Abbate, G. F. Gensini, and A. Casini, "Adherence to Mediterranean diet and health status: metaanalysis, " British Medical Journal, vol. 337, p. a1344, 2008.
2. N. Scarmeas, Y. Stern, M.-X. Tang, R. Mayeux, and J. A. Luchsinger, "Mediterranean diet and risk for Alzheimers disease, " Annals of Neurology, vol. 59, no. 6, pp. 912-921, 2006.
3. N. Scarmeas, J. A. Luchsinger, R. Mayeux, and Y. Stern, "Mediterranean diet and Alzheimer disease mortality, " Neurology, vol. 69, no. 11, pp. 1084-1093, 2007.
4. R. Estruch, E. Ros, J. Salas-Salvado, et al., "Primary prevention of cardiovascular disease with a Mediterranean diet, " The New England Journal of Medicine, vol. 368, no. 14, pp. 1279-1290, 2013.
5. J. H. Lee, J. H. O'Keefe, C. J. Lavie, R. Marchioli, and W. S. Harris, "Omega-3 fatty acids for cardioprotection, " Mayo Clinic Proceedings, vol. 83, no. 3, pp. 324-332, 2008.
6. C. Iadecola, "Neurovascular regulation in the normal brain and in Alzheimers disease, " Nature Reviews Neuroscience, vol. 5, no. 5, pp. 347-360, 2004.
7. F. Thies, J. M. C. Garry, P. Yaqoob, et al., "Association of n polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial, " The Lancet, vol. 361, no. 9356, pp. 477-485, 2003.
8. J. M. Geleijnse, E. J. Giltay, D. E. Grobbee, A. R. T. Donders, and F. J. Kok, "Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials, " Journal of Hypertension, vol. 20, no. 8, pp. 1493-1499, 2002.
9. M. L. Daviglus, J. Stamler, A. J. Orencia, et al., "Fish consumption and the 30-year risk of fatal myocardial infarction, " The New England Journal ofMedicine, vol. 336, no. 15, pp. 1046-1053, 1997.
10. F. B. Hu, L. Bronner, W. C. Willett, et al., "Fish and omega-3 fatty acid intake and risk of coronary heart disease in women, " The Journal of the AmericanMedical Association, vol. 287, no. 14, pp. 1815-1821, 2002.
11. C. von Schacky and W. S. Harris, "Cardiovascular benefits of omega-3 fatty acids, " Cardiovascular Research, vol. 73, no. 2, pp. 310-315, 2007.
12. R. J. Wurtman, M. Cansev, T. Sakamoto, and I. Ulus, "Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses, " Nutrition Reviews, vol. 68, no. 2, pp. S88-S101, 2010.
13. S. B. Weiss and E. P. Kennedy, "The function of cytidine coenzymes in the biosynthesis of phospholipides, " The Journal of Biological Chemistry, vol. 222, no. 1, pp. 193-214, 1956.
14. R. J. Wurtman, I. H. Ulus, M. Cansev, C. J. Watkins, L. Wang, and G. Marzloff, "Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally, " Brain Research, vol. 1088, no. 1, pp. 83-92, 2006.
15. M. Cansev and R. J. Wurtman, "Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils, " Neuroscience, vol. 148, no. 2, pp. 421-431, 2007.
16. T. Sakamoto, M. Cansev, and R. J. Wurtman, "Oral supplementation with docosahexaenoic acid and uridine-5-monophosphate increases dendritic spine density in adult gerbil hippocampus, " Brain Research, vol. 1182, no. 1, pp. 50-59, 2007.
17. V. Zerbi, D. Jansen, M. Wiesmann, et al., "Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimers disease, " Neurobiology of Aging, vol. 35, no. 3, pp. 600-613, 2014.
18. M. Wiesmann, D. Jansen, V. Zerbi, L. M. Broersen, A. Garthe, and A. J. Kiliaan, "Improved spatial learning strategy and memory in aged Alzheimer AbetaPPswe/PS1dE9 mice on a multi-nutrient diet, " Journal of Alzheimers Disease, vol. 37, no. 1, pp. 233-245, 2013.
19. P. J. G. H. Kamphuis and P. Scheltens, "Can nutrients prevent or delay onset of Alzheimers disease?" Journal of Alzheimers Disease, vol. 20, no. 3, pp. 765-775, 2010.
20. J. L. Cummings, "Food for thought: Souvenaid in mild Alzheimers disease, " Journal of Alzheimers Disease, vol. 31, no. 1, pp. 237-238, 2012.
21. P. Scheltens, P. J. G. H. Kamphuis, F. R. J. Verhey, et al., "Efficacy of a medical food in mild Alzheimers disease: a randomized, controlled trial, " Alzheimers & Dementia, vol. 6, no. 1, pp. 1. e1-10. e1, 2010.
22. P. Scheltens, J. W. R. Twisk, R. Blesa, et al., "Efficacy of souvenaid in mild alzheimers disease: results from a randomized, controlled trial, " Journal of Alzheimers Disease, vol. 31, no. 1, pp. 225-236, 2012.
23. H. de Waal, C. J. Stam, M. M. Lansbergen, et al., "The effect of souvenaid on functional brain network organisation in patients with mild Alzheimers disease: a randomised controlled study, " PLoS ONE, vol. 9, no. 1, Article ID e86558, 2014.
24. A. M. Minihane, S. Khan, E. C. Leigh-Firbank, et al., "ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 8, pp. 1990-1997, 2000.
25. L. J. Whalley, I. J. Deary, J. M. Starr, et al., "n-3 Fatty acid erythrocyte membrane content, APOE 4, and cognitive variation: an observational follow-up study in late adulthood, " American Journal of Clinical Nutrition, vol. 87, no. 2, pp. 449-454, 2008.
26. C. Samieri, S. Lorrain, B. Buaud, et al., "Relationship between diet and plasma long-chain n-3 PUFAs in older people: impact of apolipoprotein E genotype, " Journal of Lipid Research, vol. 54, no. 9, pp. 2559-2567, 2013.
27. V. I. Zannis, J. L. Breslow, G. Utermann, et al., "Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes, " Journal of Lipid Research, vol. 23, no. 6, pp. 911914, 1982.
28. C. Frieden and K. Garai, "Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimers disease, " Proceedings of the National Academy of Sciences of theUnited States ofAmerica, vol. 109, no. 23, pp. 8913-8918, 2012.
29. C. C. Liu, T. Kanekiyo, H. Xu, and G. Bu, "Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy, " Nature Reviews Neurology, vol. 9, no. 2, pp. 106-118, 2013.
30. B. V. Zlokovic, "Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease, " JAMA Neurology, vol. 70, no. 4, pp. 440-444, 2013.
31. K. Rannikmae, R. N. Kalaria, S. M. Greenberg, et al., "APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis, " Journal of Neurology, Neurosurgery and Psychiatry, vol. 85, no. 3, pp. 300-305, 2014.
32. K. Hultman, S. Strickland, and E. H. Norris, "The APOE 4/4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimers disease patients, " Journal of Cerebral Blood Flow and Metabolism, vol. 33, no. 8, pp. 1251-1258, 2013.
33. C. Knouff, M. E. Hinsdale, H. Mezdour, et al., "Apo E structure determines VLDL clearance and atherosclerosis risk in mice, " Journal of Clinical Investigation, vol. 103, no. 11, pp. 1579-1586, 1999.
34. J. Yin, G. H. Turner, S. W. Coons, M. Maalouf, E. M. Reiman, and J. Shi, "Association of amyloid burden, brain atrophy and memory deficits in aged apolipoprotein epsilon4 mice, " Current Alzheimer Research, vol. 11, no. 3, pp. 283-290, 2014.
35. D. Jansen, V. Zerbi, C. I. Janssen, et al., "Impact of a multinutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice, " Brain Structure and Function, vol. 219, no. 5, pp. 1841-1868, 2014.
36. P. M. Sullivan, H. Mezdour, Y. Aratani, et al., "Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis, " The Journal of Biological Chemistry, vol. 272, no. 29, pp. 17972-17980, 1997.
37. P. G. Reeves, F. H. Nielsen, and G. C. Fahey Jr., "AIN-93 purified diets for laboratory rodents: final report of the American Institute ofNutrition ad hocwriting committee on the reformulation of the AIN-76A rodent diet, " The Journal of Nutrition, vol. 123, no. 11, pp. 1939-1951, 1993.
38. S.-G. Kim, "Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping, " Magnetic Resonance in Medicine, vol. 34, no. 3, pp. 293-301, 1995.
39. L.-A. Harsan, D. Paul, S. Schnell, et al., "In vivo diffusion tensor magnetic resonance imaging and fiber tracking of the mouse brain, " NMR in Biomedicine, vol. 23, no. 7, pp. 884-896, 2010.
40. M. P. Zwiers, "Patching cardiac and head motion artefacts in diffusion-weighted images, " NeuroImage, vol. 53, no. 2, pp. 565-575, 2010.
41. G. Paxinos and K. Franklin, The Mouse Brain in Stereotaxic Coordinates, Academic Press, San Diego, Calif, USA, 2001.
42. S. J. Sawiak, N. I. Wood, G. B. Williams, A. J. Morton, and T. A. Carpenter, "Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry, " Neurobiology of Disease, vol. 33, no. 1, pp. 20-27, 2009.
43. E. Jonckers, J. vanAudekerke, G. deVisscher, A. van der Linden, and M. Verhoye, "Functional connectivity fMRI of the rodent brain: comparison of functional connectivity networks in rat and mouse, " PLoS ONE, vol. 6, no. 4, Article ID e18876, 2011.
44. D. Lutjohann, A. Brzezinka, E. Barth, et al., "Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain, " Journal of Lipid Research, vol. 43, no. 7, pp. 1078-1085, 2002.
45. R. W. Mahley and S. C. Rall Jr., "Apolipoprotein E: far more than a lipid transport protein, " Annual Review of Genomics and Human Genetics, vol. 1, pp. 507-537, 2000.
46. R. W. Mahley, K. H. Weisgraber, and Y. Huang, "Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimers disease, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 15, pp. 5644-5651, 2006.
47. P. B. Verghese, J. M. Castellano, and D. M. Holtzman, "Apolipoprotein E in Alzheimers disease and other neurological disorders, "TheLancetNeurology, vol. 10, no. 3, pp. 241-252, 2011.
48. B. V. Zlokovic, "Neurovascular pathways to neurodegeneration in Alzheimers disease and other disorders, " Nature Reviews Neuroscience, vol. 12, no. 12, pp. 723-738, 2011.
49. Y. I. Sheline, J. C. Morris, A. Z. Snyder, et al., "APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF A42, " Journal of Neuroscience, vol. 30, no. 50, pp. 17035-17040, 2010.
50. V. Zerbi, M. Wiesmann, T. L. Emmerzaal, et al., "Resting-state functional connectivity changes in aging apoE4 and apoE-KO mice, " The Journal of Neuroscience, vol. 34, no. 42, pp. 13963-13975, 2014.
51. Z. Wang, S. R. Das, S. X. Xie, S. E. Arnold, J. A. Detre, and D. A. Wolk, "Arterial spin labeled MRI in prodromal Alzheimers disease: a multi-site study, " NeuroImage: Clinical, vol. 2, no. 1, pp. 630-636, 2013.
52. P. Vemuri, H. J. Wiste, S. D. Weigand, et al., "SerialMRI andCSF biomarkers in normal aging, MCI, and AD, " Neurology, vol. 75, no. 2, pp. 143-151, 2010.
53. C. R. Jack Jr., D. S. Knopman, W. J. Jagust, et al., "Tracking pathophysiological processes in Alzheimers disease: an updated hypothetical model of dynamic biomarkers, " The Lancet Neurology, vol. 12, no. 2, pp. 207-216, 2013.
54. C. R. Jack Jr., V. J. Lowe, S. D. Weigand, et al., "Serial PIB and MRI in normal, mild cognitive impairment and Alzheimers disease: implications for sequence of pathological events in Alzheimers disease, " Brain, vol. 132, no. 5, pp. 1355-1365, 2009.
55. V. Heise, N. Filippini, A. J. Trachtenberg, S. Suri, K. P. Ebmeier, and C. E. Mackay, "Apolipoprotein E genotype, gender and age modulate connectivity of the hippocampus in healthy adults, " NeuroImage, vol. 98, pp. 23-30, 2014.
56. V. Heise, N. Filippini, K. P. Ebmeier, and C. E. MacKay, "The APOE 4 allele modulates brain white matter integrity in healthy adults, "Molecular Psychiatry, vol. 16, no. 9, pp. 908-916, 2011.
57. J. Nierenberg, N. Pomara, M. J. Hoptman, J. J. Sidtis, B. A. Ardekani, and K. O. Lim, "Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers, " NeuroReport, vol. 16, no. 12, pp. 1369-1372, 2005.
58. R. A. Honea, E. Vidoni, A. Harsha, and J. M. Burns, "Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study, " Journal of AlzheimersDisease, vol. 18, no. 3, pp. 553-564, 2009.
59. J. Kim, J. M. Basak, and D. M. Holtzman, "The role of apolipoprotein E in Alzheimers disease, " Neuron, vol. 63, no. 3, pp. 287-303, 2009.
60. L. T. Westlye, I. Reinvang, H. Rootwelt, and T. Espeseth, "Effects of APOE on brain white matter microstructure in healthy adults, " Neurology, vol. 79, no. 19, pp. 1961-1969, 2012.
61. N. Scarmeas and Y. Stern, "Imaging studies andAPOE genotype in persons at risk for Alzheimers disease, " Current Psychiatry Reports, vol. 8, no. 1, pp. 11-17, 2006.
62. C. E. Wierenga, L. R. Clark, S. I. Dev, et al., "Interaction of age and APOE genotype on cerebral blood flow at rest, " Journal of Alzheimers Disease, vol. 34, no. 4, pp. 921-935, 2013.
63. J. L. O'Brien, K. M. O'Keefe, P. S. Laviolette, et al., "Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline, " Neurology, vol. 74, no. 24, pp. 1969-1976, 2010.
64. M. M. Machulda, D. T. Jones, P. Vemuri, et al., "Effect of APOE epsilon4 status on intrinsic network connectivity in cognitively normal elderly subjects, " Archives of Neurology, vol. 68, no. 9, pp. 1131-1136, 2011.
65. J. A. Brown, K. H. Terashima, A. C. Burggren, et al., "Brain network local interconnectivity loss in aging APOE-4 allele carriers, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 51, pp. 20760-20765, 2011.
66. I. Reinvang, T. Espeseth, and L. T. Westlye, "APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimers disease, " Neuroscience and Biobehavioral Reviews, vol. 37, no. 8, pp. 1322-1335, 2013.
67. N. van Wijk, L. M. Broersen, M. C. De Wilde, et al., "Targeting synaptic dysfunction in Alzheimers disease by administering a specific nutrient combination, " Journal of Alzheimers Disease, vol. 38, no. 3, pp. 459-479, 2014.
68. C. Dawczynski, L. Martin, A. Wagner, and G. Jahreis, "n-3 LCPUFA-enriched dairy products are able to reduce cardiovascular risk factors: a double-blind, cross-over study, " Clinical Nutrition, vol. 29, no. 5, pp. 592-599, 2010.
69. E. I. Lev, A. Solodky, N. Harel, et al., "Treatment of aspirinresistant patients with omega-3 fatty acids versus aspirin dose escalation, " Journal of the American College of Cardiology, vol. 55, no. 2, pp. 114-121, 2010.
70. V. Schiano, E. Laurenzano, G. Brevetti, et al., "Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function, " Clinical Nutrition, vol. 27, no. 2, pp. 241-247, 2008.
71. A. Zampelas, "Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability, " Atherosclerosis, vol. 212, no. 1, pp. 34-35, 2010.
72. A. D. Dangour, P. J. Whitehouse, K. Rafferty, et al., "Bvitamins and fatty acids in the prevention and treatment of Alzheimers disease and dementia: a systematic review, " Journal of Alzheimers Disease, vol. 22, no. 1, pp. 205-224, 2010.
73. S. M. Artham, C. J. Lavie, R. V. Milani, R. G. Anand, J. H. O'Keefe, and H. O. Ventura, "Fish oil in primary and secondary cardiovascular prevention, " Ochsner Journal, vol. 8, no. 2, pp. 49-60, 2008.
74. J.-M. Bourre, M. Francois, A. Youyou, et al., "The effects of dietary β-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats, " Journal of Nutrition, vol. 119, no. 12, pp. 1880-1892, 1989.
75. J. M. Bourre, O. Dumont, M. Piciotti, et al., "Essentiality of omega 3 fatty acids for brain structure and function, " World Review of Nutrition and Dietetics, vol. 66, pp. 103-117, 1991.
76. E. Farkas, M. C. De Wilde, A. J. Kiliaan, J. Meijer, J. N. Keijser, and P. G. M. Luiten, "Dietary long chain PUFAs differentially affect hippocampal muscarinic 1 and serotonergic 1A receptors in experimental cerebral hypoperfusion, " Brain Research, vol. 954, no. 1, pp. 32-41, 2002.
77. D. Lutjohann, O. Breuer, G. Ahlborg, et al., "Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 18, pp. 9799-9804, 1996.
78. E. G. Lund, J. M. Guileyardo, and D. W. Russell, "cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain, " Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 13, pp. 7238-7243, 1999.
79. J. Koschack, D. Lutjohann, C. Schmidt-Samoa, and E. Irle, "Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals, " Neurobiology ofAging, vol. 30, no. 6, pp. 898-902, 2009.
80. I. Bjorkhem, D. Lutjohann, O. Breuer, A. Sakinis, and A. Wennmalm, "Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro, " Journal of Biological Chemistry, vol. 272, no. 48, pp. 30178-30184, 1997.
81. D. Jansen, V. Zerbi, I. A. C. Arnoldussen, et al., "Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in APPswe-PS1dE9 mice, " PLoS ONE, vol. 8, no. 9, Article ID e75393, 2013.
82. R. J. Wurtman, M. Cansev, T. Sakamoto, and I. H. Ulus, "Use of phosphatide precursors to promote synaptogenesis, " Annual Review of Nutrition, vol. 29, pp. 59-87, 2009.
83. R. Altman and J. C. Rutledge, "The vascular contribution to Alzheimers disease, " Clinical Science, vol. 119, no. 10, pp. 407-421, 2010.
84. D. Holland, R. S. Desikan, A. M. Dale, and L. K. McEvoy, "Higher rates of decline for women and apolipoprotein E4 carriers, " American Journal of Neuroradiology, vol. 34, no. 12, pp. 2287-2293, 2013.
85. H. Dhungana, T. Rolova, E. Savchenko, et al., "Western-type diet modulates inflammatory responses and impairs functional outcome following permanent middle cerebral artery occlusion in aged mice expressing the human apolipoprotein E4 allele, " Journal of Neuroinflammation, vol. 10, article 102, 2013.